The Sherwin-Williams Company SHW
Verdict: Sell. Fair value $203 against a price of $341 on 6 Jan 2026, 40% below the price.
In plain words
The case for: Wide competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: Intense competitive pressure could compress margins. Revenue growth has decelerated sharply from 11.1% in 2022 to 4.1% in 2023, and further to just 0.2%.... The OCF / Net Income ratio dipped to 0.95 in 2022, indicating a period of working capital stress....
Main risks
- High Leverage: A Debt/Equity ratio of 2.94 and a Total Debt/EBITDA ratio of 3.62 indicate a significant debt burden, increasing financial risk if earnings or cash flows were to decline.
- Decelerating Revenue Growth: Revenue growth has slowed dramatically from a 5.0% 3-year CAGR to just 0.2% in the most recent year, signaling potential market saturation or increased competitive pressures.
- FCF Volatility: Annual Free Cash Flow dropped from $2.63B in 2023 to $2.08B in 2024, a 21% decrease. While TTM FCF has recovered somewhat, this volatility warrants monitoring.
- Intense competitive environment
- Valuation prices in optimistic scenario (limited margin for error)